TV News LIES

A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges over an alleged scheme to hide federal records during the COVID-19 pandemic, the Justice Department said Tuesday.

Dr. David Morens, 78, was indicted by a federal grand jury earlier this month and charged with five counts, including conspiracy, destruction of records in federal investigations, and concealment of records. He made his initial appearance before a federal magistrate judge Monday and is set to be arraigned next week.

Morens served as a senior adviser to NIAID's Office of the Director from 2006 through 2022. Dr. Anthony Fauci led the institute for nearly 40 years, serving under seven presidents, and retired in 2022 during then-President Joe Biden's administration.

Prosecutors allege that Morens and two unnamed, unindicted co-conspirators worked together to defraud the U.S. by shielding federal records related to the pandemic from the public. The first co-conspirator, identified as "co-conspirator 1," served as the president and CEO of a New York-based nonprofit group that received a grant in 2014 titled "Understanding the Risk of Bat Coronavirus Emergence."

More...

Donald Trump has selected Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC), bringing to an end a months-long search for a permanent head of the troubled public health agency.

Trump revealed his choice on Truth Social, saying: “I am pleased to announce the new leadership of the Centers for Disease Control and Prevention (CDC). It is my Honor to nominate the incredibly talented Dr Erica Schwartz, MD, JD, MPH, as my Director of the CDC,” he wrote. “She is a STAR!”

Schwartz must receive confirmation from the Senate before taking the role.

A rear admiral in the US Coast Guard, Schwartz previously served as deputy surgeon general during Trump’s first administration. Over more than two decades, she has held positions in the US navy, the Public Health Service Commissioned Corps and the US Coast Guard. Her tenure as deputy surgeon general lasted from 2019 to 2021.

Schwartz is a physician with a background that includes a bachelor’s degree in biomedical engineering and a medical degree from Brown University. She also has a master’s degree in public health from the Uniformed Services University of the Health Sciences, as well as a law degree from the University of Maryland.

More...

The Supreme Court sided with a Christian counselor on Tuesday in her free speech challenge to Colorado’s ban on counselors attempting to change a minor’s sexual orientation or gender identity.

Justice Neil Gorsuch, writing for the 8-1 majority, said lower courts used too lenient a standard in upholding the ban.

The law regulates counselors’ speech in an attempt to silence a certain viewpoint, Gorsuch wrote.

“Fortunately, that is not the world the First Amendment envisions for us,” the justice wrote.

The court’s decision is poised to have ripple effects across the country, with more than 20 states having enacted similar measures. But two of the court’s liberal justices, Elena Kagan and Sonia Sotomayor, signaled that states that write more tailored laws could still prevail.

More...

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has said Dunkin’ and other companies will need to prove that their ingredients are safe, prompting Massachusetts Gov. Maura Healey (D) on Wednesday to reply back, “Come and take it.”

Kennedy, while at a rally at Brazos Hall last week in Austin, Texas, said, “We’re going to ask Dunkin’ Donuts and Starbucks, ‘Show us the safety data that show that it’s OK for a teenage girl to drink an iced coffee with 115 grams of sugar in it.'”

He added, as the audience applauded, “I don’t think they’re going to be able to do it.

“The reforms aim to ensure American foods follow the highest safety and nutritional standards globally,” MAHA Action, Kennedy’s nonprofit health advocacy group, said in a statement explaining Kennedy’s announcement.

More...

Since September, 16 major drug companies have inked deals with the Trump administration to lower prices. But in January — the time of year when pharmaceutical companies typically roll out price hikes — all 16 companies released higher list prices for some of their drugs.

The agreements, nicknamed "most favored nation" deals, were aimed at getting lower prices for American consumers and pushing other wealthy countries to pay higher prices for new drugs.

But drug companies, including the 16 that made deals, raised the prices of 872 brand-name drugs in the first two weeks of 2026, according to a new analysis by 46brooklyn, a drug price research firm.The drugs with price hikes included medicines to treat cancer, heart failure and Type 2 diabetes. The price of some COVID shots also went up.

"The real truth serum is what's happening in the marketplace after those deals occur," says Antonio Ciaccia, CEO of 46brooklyn, a nonprofit that tracks the list prices of prescription medications. "January is prime time for list price changes on brand-name drugs. So in examining where we are today, we're pretty much in line with the last few years."

More...

Dr. Kade Goepferd watched the Trump administration's moves on Thursday to ban gender-affirming care for transgender youth with "a mix of sadness and frustration."

Goepferd, who is the founder of Children's Minnesota Gender Health Program, says that for the medical community, nothing has changed about the evidence supporting gender-affirming care that could justify the government's actions.

"There's a massive propaganda and disinformation campaign that is selectively targeting this small population of already vulnerable kids and their families," Goepferd says.

Federal health officials said many times at Thursday's announcement that their actions were driven by science and evidence, not politics or ideology. They frequently praised a report published by the Department of Health and Human Services in November. It concluded that clinicians who provide medical care to help youth transition have failed their patients and emphasized the benefits of psychotherapy as an alternative.

More...